Matrix metalloproteinases and their tissue inhibitors in the lesions of cardiac and pulmonary sarcoidosis: An immunohistochemical study

Human Pathology

Volumn 33, Issue 12, 2002, Pages 1158-1164

  González, A Adrián ^a,b,c   Segura, Ana M ^a,b,c   Horiba, Koji ^a,b,c   Qian, Sujuan ^a,b,c   Yu, Zu Xi ^a,b,c   Stetler Stevenson, William ^a,b,c   Willerson, James T ^a,b,c   McAllister Jr , Hugh A ^a,b,c   Ferrans, Victor J ^a,b,c  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b ST LUKE S EPISCOPAL HOSPITAL   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Heart disease; Immunohistochemistry; Lung disease; Metalloproteinases; Sarcoidosis

Indexed keywords

MATRIX METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HEART DISEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LUNG DISEASE; LUNG SARCOIDOSIS; SARCOIDOSIS;

EID: 0036912183     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1053/hupa.2002.129423     Document Type: Article

References (33)

1. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous disorders (WASOG) adopted by the ATS Board of Directors and by the ERE Executive Committee, February 1999. Am J Respir Crit Care Med 160:736-755, 1999
2. Roberts WC, McAllister HA Jr, Ferrans VJ: Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group I) and review of 78 previously described necropsy patients (group II). Am J Med 63:86-108, 1977
3. McDonnel S, Morgan M, Lynch C: Role of matrix metalloproteinases in normal and disease processes. Biochem Soc Trans 27:734-740, 1999
4. Nagase H: Activation mechanisms of matrix metalloproteinases. Biol Chem 378:151-160, 1997
5. Murphy G, Stanton H, Cowell S, et al: Review article: Mechanisms for pro-matrix metalloproteinase activation. APMIS 107:33-44, 1999
6. Hayashi T, Stetler-Stevenson WG, Fleming M, et al: Immunohistochemical study of metalloproteinases and their tissue inhibitors in the lungs of patients with diffuse alveolar damage and idiopathic pulmonary fibrosis. Am J Pathol 149:1241-1256, 1996
7. Hong BK, Kwon HM, Lee BK, et al: Coexpression of cyclooxygenase-2 and matrix metalloproteinases in human aortic atherosclerotic lesions. Yonsei Med J 41:82-88, 2000
8. Palombo D, Maione M, Cifiello BI, et al: Matrix metalloproteinases. Their role in degenerative chronic diseases of abdominal aorta. J Cardiovasc Surg (Torino) 40:257-260, 1999
9. Elmore JR, Keister BF, Franklin DP, et al: Expression of matrix metalloproteinases and TIMPs in human abdominal aortic aneurysms. Ann Vasc Surg 12:221-228, 1998
10. Thompson RW, Baxter BT: MMP inhibition in abdominal aortic aneurysm. Rationale for a prospective randomized clinical trial. Ann N Y Acad Sci 878:159-178, 1999
11. Gaetani P, Radriguez Y, Baena R, et al: Metalloproteases and intracranial vascular lesions. Neurol Res 1:385-390, 1999
12. Segura AM, Luna RE, Horiba K, et al: Immunohistochemistry of matrix metalloproteinases and their inhibitors in thoracic aortic aneurysms and aortic valves of patients with Marfan's syndrome. Circulation 98:11331-11337, 1998
13. Lu L, Gunja-Smith Z, Woessner JF, et al: Matrix metalloproteinases and collagen ultrastructure in moderate myocardial ischemia and reperfusion in vivo. Am J Physiol Heart Circ Physiol 279:H601-H609, 2000
14. Peterson JT, Li H, Dillon L, et al: Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat. Cardiovasc Res 46:307-315, 2000
15. Tyagi SC, Kumar SG, Haas SJ, et al: Post-transcriptional regulation of extracellular matrix metalloproteinase in human heart end-stage failure secondary to ischemic cardiomyopathy. J Mol Cell Cardiol 28:1415-1428, 1996
16. Li YY, Feldman AM, Sun Y: Differential expression of tissue inhibitors of metalloproteinases in the failing human heart. Circulation 98:1728-1734, 1998
17. Hayashi T, Shimomura H, Terasaki F, et al: Collagen subtypes and matrix metalloproteinase in idiopathic restrictive cardiomyopathy. Int J Cardiol 64:109-116, 1998
18. Thomas CV, Coker ML, Zellner JL, et al: Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy. Circulation 97:1708-1715, 1998
19. Coker ML, Thomas CV, Clair MJ, et al: Myocardial matrix metalloproteinase activity and abundance with congestive heart failure. Am J Physiol 274:H1516-H1523, 1998
20. Rao VU, Spinale FG: Controlling myocardial matrix remodeling: Implications for heart failure. Cardiol Rev 7:136-143, 1999
21. Simionescu A, Simionescu D, Deac RFP, et al: Matrix metalloproteinases in the pathology of natural and bioprosthetic cardiac valves. Cardiovasc Pathol 5:323-332, 1996
22. Tyagi SC, Campbell SE, Reddy HK, et al: Matrix metalloproteinase activity expression in infarcted, noninfarcted and dilated cardiomyopathic human hearts. Mol Cell Biochem 155:13-21, 1996
23. Schroen DJ, Brinckerhoff CE: Nuclear hormone receptors inhibit matrix metalloproteinase (MMP) gene expression through diverse mechanisms. Gene Expr 6:197-207, 1996
24. Ward K, O'Connor CM, Odlum C, et al: Pulmonary disease progress in sarcoid patients with and without bronchoalveolar lavage collagenase. Am Rev Respir Dis 142:636-641, 1990
25. Jimenez-Garcia LF, Perez-Ramos J, Selman M, et al: Cellular source of collagenase and TIMP-1 in carrageenin-induced granuloma. Exp Mol Pathol 60:130-139, 1994
26. Trancart MM, Chalmeigne N, Girardot C, et al: Gelatinase is the main matrix metalloproteinase involved in granuloma-induced cartilage degradation. Int J Tissue React 14:287-294, 1992
27. Saarialho-Kere UK, Chang ES, Welgus HG, et al: Distinct localization of collagenase and tissue inhibitor of metalloproteinases expression in wound healing associated with ulcerative pyogenic granuloma. J Clin Invest 90:1952-1957, 1992
28. Saarialho-Kere UK, Chang ES, Welgus HG, et al: Expression of interstitial collagenase, 92-kDa gelatinase, and tissue inhibitor of metalloproteinases-1 in granuloma annulare and necrobiosis lipoidica diabeticorum. J Invest Dermatol 100:335-342, 1993
29. Maeda H, Okamoto T, Akaike T: Human matrix metalloprotease activation by insults of bacterial infection involving proteases and free radicals. Biol Chem 379:193-200, 1998
30. Hayashi T, Rush WL, Travis WD, et al: Immunohistochemical study of matrix metalloproteinases and their tissue inhibitors in pulmonary Langerhans' cell granulomatosis. Arch Pathol Lab Med 121:930-937, 1997
31. Hayashi T, Fleming MV, Stetler-Stevenson WG, et al: Immunohistochemical study of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in pulmonary lymphangioleiomyomatosis (LAM). Hum Pathol 28:1071-1078, 1997
32. Galateau-Salle FB, Luna RE, Horiba K, et al: Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in bronchial squamous preneoplastic lesions. Mod Pathol 11:174A, 1999
33. Guinec N, Dalet-Fumeron V, Pagano M: In vitro study of basement membrane degradation by the cysteine proteinases, cathepsins B, B-like and L. Biol Chem Hoppe Seyler 374:1135-1146, 1993